The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Synthetic organisms, mirror-reversed on the molecular level from natural life, could be a possibility within decades. They could interact with humans and the environment in unpredictable, potentially dangerous ways.
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”
Taking care of a sick or aging family member can be exhausting. If you feel overwhelmed, you're not alone. Here are some ways to relieve some of the pressure.
NASA crew and ground-based scientists are sending blood cells to the International Space Station on November 4 to learn why astronauts have a higher risk of blood clots.
The Division of Hematology at the University of Utah's Department of Internal Medicine is pleased to announce that Anna Beaudin, PhD, has been named the inaugural holder of the John...
